Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Uterine Cervical Neoplasms 4Glioblastoma 3Esophageal Neoplasms 3Recurrence 2Esophageal Squamous Cell Carcinoma 2Endometrial Neoplasms 2Brain Neoplasms 2Thyroid Neoplasms 1Pathologic Complete Response 1Oligodendroglioma 1Lymphoma, Follicular 1Lymphatic Metastasis 1Li-Fraumeni Syndrome 1Gliosarcoma 1Glioma 1Ependymoma 1Disease 1DWI-MRI 1Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Astrocytoma 1Adenocarcinoma Of Esophagus 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Diffusion Magnetic Resonance Imaging × Clear all
NCT02679586 2016-02-11

Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Completed
25 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡